FLU-M Tetra
Showing 1 - 25 of 3,687
Influenza, Influenza, Human, Influenza Viral Infections Trial in Russian Federation (Influenza vaccine [inactivated])
Recruiting
- Influenza
- +3 more
- Influenza vaccine [inactivated]
-
Ekaterinburg, Russian Federation
- +6 more
Feb 13, 2023
Influenza Trial in Russian Federation (Flu-M Tetra [Inactivated split influenza vaccine] w/p, Flu-M Tetra [Inactivated split
Completed
- Influenza
- Flu-M Tetra [Inactivated split influenza vaccine] w/p
- +2 more
-
Engels, Russian Federation
- +10 more
Mar 25, 2022
Influenza, Influenza, Human, Influenza Viral Infections Trial in Russian Federation (Influenza vaccine [inactivated])
Completed
- Influenza
- +4 more
- Influenza vaccine [inactivated]
-
Kol'tsovo, Novosibirsk Region, Russian Federation
- +4 more
May 11, 2023
Influenza Trial in Novosibirsk (Flu-M Quadro [inactivated split influenza vaccine] with preservative, Flu-M Quadro [inactivated
Completed
- Influenza
- Flu-M Quadro [inactivated split influenza vaccine] with preservative
- +2 more
-
Novosibirsk, Russian FederationFederally Funded Healthcare Institution Primary Healthcare Unit
Dec 16, 2021
Influenza, Human, Vaccination; Infection, Vaccines Trial in Saint Petersburg (Flu-M, Inactivated split influenza vaccine 0.5 mL,
Completed
- Influenza, Human
- +2 more
- Flu-M, Inactivated split influenza vaccine 0.5 mL
- +3 more
-
Saint Petersburg, Russian Federation
- +1 more
Jul 19, 2022
Influenza, Flu, Human Trial in Russian Federation (Flu-M [inactivated split influenza vaccine] without preservative, Flu-M
Completed
- Influenza
- Flu, Human
- Flu-M [inactivated split influenza vaccine] without preservative
- Flu-M [inactivated split influenza vaccine] with preservative
-
Engels, Russian Federation
- +7 more
Mar 28, 2022
Influenza Trial in Novosibirsk, Perm, Saint Petersburg (Flu-M [Inactivated split influenza vaccine], Inactivated influenza split
Completed
- Influenza
- Flu-M [Inactivated split influenza vaccine]
- Inactivated influenza split vaccine
-
Novosibirsk, Russian Federation
- +2 more
Mar 16, 2022
Influenza, Human, Vaccination; Infection, Vaccines Trial in Russian Federation (Flu-M, Inactivated split influenza vaccine,
Completed
- Influenza, Human
- +2 more
- Flu-M, Inactivated split influenza vaccine
- Ultrix®, Inactivated Split Influenza Vaccine
-
Barnaul, Altai Territory, Russian Federation
- +4 more
Jul 11, 2022
Influenza Trial in Perm, Saint Petersburg (Flu-M [Inactivated split influenza vaccine], Inactivated Split Influenza Vaccine)
Completed
- Influenza
- Flu-M [Inactivated split influenza vaccine]
- Inactivated Split Influenza Vaccine
-
Perm, Russian Federation
- +1 more
Mar 30, 2022
Influenza Trial in Perm (Inactivated Split Influenza Vaccine, Placebo)
Completed
- Influenza
- Inactivated Split Influenza Vaccine
- Placebo
-
Perm, Russian FederationPerm State Medical University named after academician E.A. Wagne
Dec 16, 2021
Influenza Vaccination Trial in United States (Question (Q), Messaging (M))
Completed
- Influenza Vaccination
- Question (Q)
- Messaging (M)
-
San Francisco, California
- +7 more
Apr 19, 2023
Microbiome, Flu Trial in Houston (High-Fiber Diet (HFD), Prebiotic Food-Enriched Diet (PreFED))
Recruiting
- Microbiome
- Flu
- High-Fiber Diet (HFD)
- Prebiotic Food-Enriched Diet (PreFED)
-
Houston, TexasM D Anderson Cancer Center
Oct 3, 2022
Influenza Trial in Saint Petersburg (Flu-M [Inactivated split influenza vaccine], Inactivated Split Influenza Vaccine)
Completed
- Influenza
- Flu-M [Inactivated split influenza vaccine]
- Inactivated Split Influenza Vaccine
-
Saint Petersburg, Russian Federation
- +1 more
Dec 16, 2021
Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, FLU vaccine)
Active, not recruiting
- Respiratory Syncytial Virus Infections
- RSVPreF3 OA investigational vaccine
- FLU vaccine
-
Edegem, Belgium
- +33 more
Dec 7, 2022
Influenza Trial in Kraków (M-001, Saline)
Completed
- Influenza
- M-001
- Saline
-
Kraków, Ul. Bobrzyńskiego 14,, Poland
- +1 more
Sep 13, 2021
Healthy Trial (IL-YANG FLU Vaccine Prefilled Syringe INJ., Fluarix Tetra Pre-filled Syringe)
Not yet recruiting
- Healthy
- IL-YANG FLU Vaccine Prefilled Syringe INJ.
- Fluarix Tetra Pre-filled Syringe
- (no location specified)
Aug 23, 2021
SARS-CoV-2 Infection, Coronavirus Disease 2019 (COVID-19) Trial (SARS-CoV-2 mRNA Vaccine (CVnCoV), Quadrivalent influenza
Withdrawn
- SARS-CoV-2 Infection
- Coronavirus Disease 2019 (COVID-19)
- SARS-CoV-2 mRNA Vaccine (CVnCoV)
- +2 more
- (no location specified)
Aug 4, 2021
Endovascular Coiling Using Target Tetra® Coils for Small
Not yet recruiting
- Intracranial Aneurysm
-
Seoul, Korea, Republic ofSeverance Hospital
Sep 26, 2023
Protocol for Muscle Invasive Urothelial Carcinoma of Urinary
Recruiting
- Bladder Cancer
- terta modal bladder preservation
-
Assiut, Assuit, EgyptAssuit university
Aug 13, 2022
Leukemia, Stem Cell Transplant, Cord Blood Trial in Guangzhou (applying of FLU+CY post-HSCT)
Recruiting
- Leukemia
- +2 more
- applying of FLU+CY post-HSCT
-
Guangzhou, Guangdong, ChinaNanfang Hospital
Nov 23, 2023
Health Behavior, Colorectal Cancer, Influenza Trial in New Orleans (Financial incentive for colorectal cancer screening,
Recruiting
- Health Behavior
- +6 more
- Financial incentive for colorectal cancer screening
- +2 more
-
New Orleans, LouisianaTulane University School of Medicine
Nov 13, 2023
Early Flu Shots in SOT
Withdrawn
- Influenza
- Solid Organ Transplant
- standard of care influenza vaccine
-
Toronto, Ontario, CanadaUniversity Health Network, Toronto General Hospital, Multi-Organ
Oct 16, 2020
Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Fludarabine, busulfan and melphalan
- Fludarabine and Busulfan
-
Fuzhou, Fujian, China
- +8 more
Aug 14, 2023
Ulcus Cruris, Ecthyma, Ulcer, Leg Trial in Zurich (IMP2 (lidocaine-23%-tetracaine-7% gel), IMP1 (EMLA 5% cream))
Recruiting
- Ulcus Cruris
- +3 more
- IMP2 (lidocaine-23%-tetracaine-7% gel)
- IMP1 (EMLA 5% cream)
-
Zurich, SwitzerlandDepartment of Dermatology, University Hospital of Zurich, Switze
Jun 5, 2023
Respiratory Syncytial Virus Infections Trial in Worldwide (RSV MAT Lot 1 vaccine (GSK3888550A), RSV MAT Lot 2 vaccine
Completed
- Respiratory Syncytial Virus Infections
- RSV MAT Lot 1 vaccine (GSK3888550A)
- +4 more
-
West Palm Beach, Florida
- +35 more
Jul 14, 2022